Allied Healthcare Products
Market Cap
US$17.5m
Last Updated
2021/04/12 23:32 UTC
Data Sources
Company Financials
Executive Summary
Allied Healthcare Products, Inc. manufactures and markets respiratory products for use in the health care industry in a range of hospitals and alternate site settings worldwide. More Details
Rewards
Risk Analysis
Snowflake Analysis
Imperfect balance sheet and overvalued.
Share Price & News
How has Allied Healthcare Products's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: AHPI is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 14% a week.
Volatility Over Time: AHPI's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of US stocks.
Market Performance
7 Day Return
-12.2%
AHPI
1.6%
US Medical Equipment
0.9%
US Market
1 Year Return
-72.1%
AHPI
42.5%
US Medical Equipment
57.9%
US Market
Return vs Industry: AHPI underperformed the US Medical Equipment industry which returned 40.4% over the past year.
Return vs Market: AHPI underperformed the US Market which returned 56.3% over the past year.
Shareholder returns
| AHPI | Industry | Market | |
|---|---|---|---|
| 7 Day | -12.2% | 1.6% | 0.9% |
| 30 Day | -12.6% | 4.1% | 2.3% |
| 90 Day | -21.8% | 2.5% | 6.3% |
| 1 Year | -72.1%-72.1% | 43.7%42.5% | 60.8%57.9% |
| 3 Year | 70.0%70.0% | 75.8%71.7% | 64.5%53.9% |
| 5 Year | 216.7%216.7% | 140.8%124.1% | 120.9%96.4% |
Long-Term Price Volatility Vs. Market
How volatile is Allied Healthcare Products's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 months ago | Simply Wall St
A Quick Analysis On Allied Healthcare Products' (NASDAQ:AHPI) CEO Compensation3 months ago | Simply Wall St
Here's Why Allied Healthcare Products (NASDAQ:AHPI) Can Afford Some Debt5 months ago | Simply Wall St
What We Learned About Allied Healthcare Products' (NASDAQ:AHPI) CEO PayValuation
Is Allied Healthcare Products undervalued compared to its fair value and its price relative to the market?
1.86x
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate AHPI's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate AHPI's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: AHPI is unprofitable, so we can't compare its PE Ratio to the US Medical Equipment industry average.
PE vs Market: AHPI is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate AHPI's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: AHPI is good value based on its PB Ratio (1.9x) compared to the US Medical Equipment industry average (5x).
Future Growth
How is Allied Healthcare Products forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
16.9%
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Allied Healthcare Products has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Past Performance
How has Allied Healthcare Products performed over the past 5 years?
2.7%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: AHPI is currently unprofitable.
Growing Profit Margin: AHPI is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: AHPI is unprofitable, but has reduced losses over the past 5 years at a rate of 2.7% per year.
Accelerating Growth: Unable to compare AHPI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: AHPI is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).
Return on Equity
High ROE: AHPI has a negative Return on Equity (-3.41%), as it is currently unprofitable.
Financial Health
How is Allied Healthcare Products's financial position?
Financial Position Analysis
Short Term Liabilities: AHPI's short term assets ($15.4M) exceed its short term liabilities ($10.0M).
Long Term Liabilities: AHPI's short term assets ($15.4M) exceed its long term liabilities ($569.9K).
Debt to Equity History and Analysis
Debt Level: AHPI's debt to equity ratio (47.6%) is considered high.
Reducing Debt: Insufficient data to determine if AHPI's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: AHPI has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: AHPI has less than a year of cash runway if free cash flow continues to reduce at historical rates of 19.5% each year
Dividend
What is Allied Healthcare Products's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate AHPI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate AHPI's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if AHPI's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if AHPI's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of AHPI's dividend in 3 years as they are not forecast to pay a notable one for the US market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
19.8yrs
Average management tenure
CEO
Earl Refsland (77 yo)
21.58yrs
Tenure
US$501,722
Compensation
Mr. Earl R. Refsland has been the President and Chief Executive Officer at Allied Healthcare Products Inc. since September 1999. From May 1995 to March 1998, Mr. Refsland served as the President and Chief ...
CEO Compensation Analysis
Compensation vs Market: Earl's total compensation ($USD501.72K) is about average for companies of similar size in the US market ($USD510.94K).
Compensation vs Earnings: Earl's compensation has been consistent with company performance over the past year.
Leadership Team
Experienced Management: AHPI's management team is seasoned and experienced (19.8 years average tenure).
Board Members
Experienced Board: AHPI's board of directors are seasoned and experienced ( 15.8 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: AHPI insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Allied Healthcare Products, Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Allied Healthcare Products, Inc.
- Ticker: AHPI
- Exchange: NasdaqCM
- Founded: 1979
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: US$17.539m
- Shares outstanding: 4.01m
- Website: https://www.alliedhpi.com
Number of Employees
Location
- Allied Healthcare Products, Inc.
- 1720 Sublette Avenue
- Saint Louis
- Missouri
- 63110
- United States
Listings
Biography
Allied Healthcare Products, Inc. manufactures and markets respiratory products for use in the health care industry in a range of hospitals and alternate site settings worldwide. The company offers respirat...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/04/12 23:32 |
| End of Day Share Price | 2021/04/12 00:00 |
| Earnings | 2020/12/31 |
| Annual Earnings | 2020/06/30 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.